Skip to main content
INDP logo

INDP · Indaptus Therapeutics, Inc.

$1.82 +0.09 (+5.20%) At close · Jul 29
Market Cap
$206.10M
Shares
113.24M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2023
Executive Total
Jeffrey A. Meckler $1,001,249
Walt A. Linscott $770,039
Michael J. Newman $718,039
Fiscal 2022
Executive Total
Jeffrey A. Meckler $1,680,532
Walt A. Linscott $848,244
Fiscal 2021
Executive Total
Jeffrey A. Meckler $1,412,237
Walt A. Linscott $1,091,642
Michael J. Newman $851,856
Fiscal 2020
Executive Total
Jeffrey A. Meckler $1,066,243
Walt A. Linscott $789,183
Michael J. Newman $200,000

Executive changes

Person Change Filed
Walt A. Linscott, Esq. Resigned 2026-06-05
Matthew McMurdo Resigned 2026-04-23
Yi Zhang Appointed 2026-04-23
Tim Ruan Appointed 2026-04-23
Yu Ding Appointed 2026-04-03
Qinglai Lu Appointed 2026-04-03
Nir Sassi Resigned 2026-04-03
David Lazar Resigned 2026-03-24
Junyi Dai Appointed 2026-03-24
David Lazar Resigned 2026-03-24
Anthony J. Maddaluna Resigned 2026-03-24
William B. Hayes Resigned 2026-03-24
Jeffrey A. Meckler Resigned 2026-03-24
Roger J. Pomerantz Resigned 2026-03-24
Jeffrey A. Meckler Resigned 2026-03-24
David Natan Appointed 2026-01-08
Anthony Maddaluna Resigned 2026-01-02
Mark Gilbert Resigned 2026-01-02
Michael Newman Resigned 2026-01-02
Key facts CIK 1857044 CUSIP 45339J204 13F (30d) 1 filings 1 filers Visit website